These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of androgen supplementation therapy on the prostate. Kaufman JM Aging Male; 2003 Sep; 6(3):166-74. PubMed ID: 14628497 [TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
5. Is there a protective role of testosterone against high-grade prostate cancer? Incidence and severity of prostate cancer in 553 patients who underwent prostate biopsy: a prospective data register. Yassin A; Salman M; Talib RA; Yassin DJ Aging Male; 2017 Jun; 20(2):125-133. PubMed ID: 28282997 [TBL] [Abstract][Full Text] [Related]
6. Effects of androgen deficiency and replacement on prostate zonal volumes. Jin B; Conway AJ; Handelsman DJ Clin Endocrinol (Oxf); 2001 Apr; 54(4):437-45. PubMed ID: 11318778 [TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy and prostate cancer--safety concerns are well founded. Klotz L Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848 [TBL] [Abstract][Full Text] [Related]
8. Prevention of prostate cancer by androgens: experimental paradox or clinical reality. Algarté-Génin M; Cussenot O; Costa P Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098 [TBL] [Abstract][Full Text] [Related]
10. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry. Morales A BJU Int; 2011 May; 107(9):1369-73. PubMed ID: 21518230 [TBL] [Abstract][Full Text] [Related]
11. Safety of androgen therapy in men with prostate cancer. Rajan P; Tharakan T; Chen R Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101628. PubMed ID: 35248487 [TBL] [Abstract][Full Text] [Related]
12. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes. Kaplan AL; Hu JC Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552 [TBL] [Abstract][Full Text] [Related]
13. Questioning the evidence behind the Saturation Model for testosterone replacement therapy in prostate cancer. Kim JW Investig Clin Urol; 2020 May; 61(3):242-249. PubMed ID: 32377599 [TBL] [Abstract][Full Text] [Related]
14. Testosterone replacement therapy in hypogonadal men at high risk for prostate cancer: results of 1 year of treatment in men with prostatic intraepithelial neoplasia. Rhoden EL; Morgentaler A J Urol; 2003 Dec; 170(6 Pt 1):2348-51. PubMed ID: 14634413 [TBL] [Abstract][Full Text] [Related]